- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Bicalutamide, CP-675,206 (tremelimumab)
Total 72 results
-
University of Wisconsin, MadisonPfizerTerminatedProstate CancerUnited States
-
Azienda Ospedaliera Universitaria SeneseMedImmune LLCUnknownMalignant MesotheliomaItaly
-
Jonsson Comprehensive Cancer CenterPfizerCompletedMelanoma (Skin)United States
-
Azienda Ospedaliera Universitaria SeneseUnknownMalignant MesotheliomaItaly
-
Clinica Universidad de Navarra, Universidad de...PfizerCompletedHepatocellular Carcinoma | Hepatitis C Virus Chronic InfectionSpain
-
PfizerWithdrawnHuman Immunodeficiency Virus
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
AstraZenecaTerminated
-
PfizerNo longer availableAdvanced Unresectable Melanoma
-
AstraZenecaCompletedMelanoma | Neoplasms | Renal Cell Carcinoma | Prostatic Neoplasms | Colorectal Neoplasms | Patients Who Have/Have Had Melanoma and Other TumorsUnited States, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Cancer | Stage IV Renal Cell Cancer AJCC v7United States
-
AstraZenecaCompletedCarcinoma, Non-small-cell LungUnited States, Canada, Korea, Republic of, United Kingdom, Czech Republic
-
AstraZenecaCompletedColorectal NeoplasmsUnited States, Canada
-
University Health Network, TorontoTerminatedMetastatic Breast CancerCanada
-
AHS Cancer Control AlbertaCompleted
-
Columbia UniversityWithdrawnNon-small Cell Lung Cancer
-
Grupo Espanol de Tumores NeuroendocrinosCompletedNeuroendocrine Tumors | Neuroendocrine Neoplasm of LungSpain
-
F. Stephen Hodi, MDMedImmune LLCCompletedMetastatic MelanomaUnited States
-
Dana-Farber Cancer InstituteAstraZenecaSuspendedMesotheliomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); MedImmune LLC; Avon Breast Cancer FoundationCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu NegativeUnited States
-
Dana-Farber Cancer InstituteAstraZenecaTerminatedRecurrent Ovarian Carcinoma | Recurrent Cervical Carcinoma | Recurrent Endometrial Cancer | Metastatic Endometrial Cancer | Metastatic Cervical Cancer | Recurrent Vaginal Cancer | Recurrent Vulvar Cancer | Metastatic Ovarian Cancer | Recurrent Gynecological Cancer | Metastatic Vaginal Cancer | Metastatic...United States
-
University of Wisconsin, MadisonPfizerWithdrawn
-
Abramson Cancer Center of the University of PennsylvaniaCompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Catherine ShuWithdrawnNonsmall Cell Lung CancerUnited States
-
AstraZenecaCompletedProstatic NeoplasmsUnited States
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Prisma Health-UpstateAstraZeneca; MedImmune LLCRecruitingCancer | Rare DiseaseUnited States
-
NYU Langone HealthAstraZenecaWithdrawnPancreatic CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMLH1 Gene Mutation | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Metastatic Carcinoma in the Liver | MSH6 Gene Mutation | PMS2 Gene MutationUnited States
-
Catherine ShuCompleted
-
AstraZenecaCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHydronephrosis | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage III Renal Pelvis Cancer AJCC v7 | Stage III Ureter Cancer AJCC v7 | Stage III Urethral Cancer AJCC v7 | Stage IV Renal Pelvis Cancer AJCC v7 | Stage IV... and other conditionsUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)CompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingUnresectable Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | BCLC Stage B Hepatocellular Carcinoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatic Colorectal Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
National Cancer Institute (NCI)CompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Carcinoma | Colorectal Adenocarcinoma | Refractory CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); AstraZeneca; MedImmune LLCCompletedMalignant Glioma | Recurrent GlioblastomaUnited States
-
Emory UniversityAstraZenecaCompletedRecurrent Small Cell Lung CarcinomaUnited States
-
Mary Feng, MDAstraZenecaRecruitingAdvanced Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatic Carcinoma in the Liver | Resectable MassUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZenecaActive, not recruitingHepatocellular Carcinoma | Intermediate Stage of Hepatocellular CarcinomaUnited States
-
Association Pour La Recherche des Thérapeutiques...Active, not recruitingInfiltrating Bladder Urothelial CarcinomaFrance
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingStage IV Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Stage IVB Bladder Cancer AJCC v8 | Bladder Urothelial CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingMetastatic Malignant Female Reproductive System Neoplasm | Platinum-Resistant Malignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System NeoplasmUnited States
-
Roswell Park Cancer InstituteAstraZenecaActive, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Serous AdenocarcinomaUnited States